Royalty Pharma plcRPRXNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank85
3Y CAGR+45.3%
5Y CAGR+9.7%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+45.3%/yr
Quarterly compound
5Y CAGR
+9.7%/yr
Recent acceleration
Percentile
P85
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 17.72% |
| Q3 2025 | 93.03% |
| Q2 2025 | -38.94% |
| Q1 2025 | -19.72% |
| Q4 2024 | 5.53% |
| Q3 2024 | 6.90% |
| Q2 2024 | -0.97% |
| Q1 2024 | -13.98% |
| Q4 2023 | 34.72% |
| Q3 2023 | -5.64% |
| Q2 2023 | -41.21% |
| Q1 2023 | 81.40% |
| Q4 2022 | 5.77% |
| Q3 2022 | -6.28% |
| Q2 2022 | 24.92% |
| Q1 2022 | -6.06% |
| Q4 2021 | 4.30% |
| Q3 2021 | -11.65% |
| Q2 2021 | 1.07% |
| Q1 2021 | -7.00% |
| Q4 2020 | 11.17% |
| Q3 2020 | 4.06% |
| Q2 2020 | 3.80% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | -100.00% |
| Q2 2019 | -22.22% |
| Q1 2019 | 0.00% |